{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:44:35Z","timestamp":1792640675907,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.neuroscience.2012.01.019","type":"journal-article","created":{"date-parts":[[2012,1,28]],"date-time":"2012-01-28T09:50:42Z","timestamp":1327744242000},"page":"79-84","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Mephedrone (\u201cbath salt\u201d) pharmacology: insights from invertebrates"],"prefix":"10.1016","volume":"208","author":[{"given":"L.","family":"Ramoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Reitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tallarida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Tallarida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.B.","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2012.01.019_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0742-8413(83)90142-1","article-title":"Effects of dopaminergic agents on monoamine levels and motor behaviour in planaria","volume":"74","author":"Algeri","year":"1983","journal-title":"Comp Biochem Physiol C"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jep.2010.07.001","article-title":"Khat chewing, cardiovascular diseases and other internal medical problems: the current situation and directions for future research","volume":"132","author":"Al-Motarreb","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib3","first-page":"399","article-title":"SCH 23390: the first selective dopamine D1-like receptor antagonist. CNS","volume":"7","author":"Bourne","year":"2001","journal-title":"Drug Res"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib4","first-page":"225","article-title":"Acetylcholine\/dopamine interaction in planaria","volume":"125","author":"Buttarelli","year":"2000","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2007.10.026","article-title":"Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms","volume":"430","author":"Chae","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00422974","article-title":"The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat","volume":"39","author":"Creese","year":"1974","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cne.903450405","article-title":"Gamma-aminobutyric acid in the nervous system of a planarian","volume":"345","author":"Eriksson","year":"1994","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1124\/jpet.111.184119","article-title":"4-Methylmethcathinone(mephedrone): neuropharmacological effects of a designer stimulant of abuse","volume":"339","author":"Hadlock","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","article-title":"SCH 23390\u2014the first selective dopamine D-1 antagonist","volume":"91","author":"Hyttel","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib10","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","article-title":"Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats","volume":"164","author":"Kehr","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib12","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1097\/00001756-200008030-00033","article-title":"Reinforcing effects of methamphetamine in planarians","volume":"11","author":"Kusayama","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euroneuro.2011.07.009","article-title":"Interaction of mephedrone with dopamine and serotonin targets in rats","volume":"22","author":"Mart\u00ednez-Clemente","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00216-010-3636-5","article-title":"Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry","volume":"397","author":"Meyer","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib15","series-title":"Mephedrone: use of Mephedrone (M-Cat, Meow) in Middlesbrough","author":"Newcombe","year":"2009"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuroscience.2010.03.038","article-title":"Analysis of motor function modulated by cholinergic neurons in planarian Dugesia japonica","volume":"168","author":"Nishimura","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pbb.2007.12.008","article-title":"Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones","volume":"89","author":"Pag\u00e1n","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2009.05.022","article-title":"A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms","volume":"615","author":"Pag\u00e1n","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0742-8413(96)00053-9","article-title":"A pharmacological study of cocaine activity in planaria","volume":"115","author":"Palladini","year":"1996","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib20","series-title":"Mephedrone report","year":"2009"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00008877-200311000-00010","article-title":"Disruption of a drug-induced choice behavior by UV light","volume":"14","author":"Raffa","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.brainres.2004.10.052","article-title":"Description and quantification of cocaine withdrawal signs in planaria","volume":"1032","author":"Raffa","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib22a","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejphar.2010.09.021","article-title":"Topiramate-antagonism of L-glutamate-induced paroxysms in planarians","volume":"649","author":"Raffa","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib23","series-title":"A model for drug action and abuse","author":"Raffa","year":"2008"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2007.12.001","article-title":"The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of \u201cpharmacologic congruence\u201d","volume":"1193","author":"Raffa","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(01)01358-9","article-title":"Cocaine withdrawal in planaria","volume":"430","author":"Raffa","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.pbb.2011.06.003","article-title":"Carbamazepine inhibits distinct chemoconvulsant-induced seizure-like activity in Dugesia tigrina","volume":"99","author":"Ramakrishnan","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pbb.2007.01.010","article-title":"An NMDA antagonist (LY235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2)","volume":"86","author":"Rawls","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/FBP.0b013e32833b0098","article-title":"First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians","volume":"21","author":"Rawls","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib29","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.neuroscience.2010.06.041","article-title":"\u03b2-lactamase inhibitors display anti-seizure properties in an invertebrate assay","volume":"169","author":"Rawls","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2011.04.001","article-title":"Nicotine behavioral pharmacology: clues from planarians","volume":"118","author":"Rawls","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pbb.2009.05.005","article-title":"Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians","volume":"93","author":"Rawls","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejphar.2008.01.012","article-title":"Parthenolide prevents the expression of cocaine-induced withdrawal behavior in planarians","volume":"583","author":"Rowlands","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2008.04.086","article-title":"Withdrawal-like behavior in planarians is dependent on drug exposure duration","volume":"439","author":"Sacavage","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0269881107079170","article-title":"Cocaine\/crack cocaine consumption, treatment demand, seizures, related offences, prices, average purity levels and deaths in the UK (1990\u20132004)","volume":"22","author":"Schifano","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa072488","article-title":"A parkinsonian syndrome in Methcathinone users and the role of manganese","volume":"358","author":"Stepens","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00442011","article-title":"Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization","volume":"98","author":"Ujike","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vascn.2010.08.002","article-title":"Glutamate and aspartate measurements in individual planaria by rapid capillary electrophoresis","volume":"63","author":"Vyas","year":"2010","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib38","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(10)62021-1","article-title":"Mephedrone: still available and twice the price","volume":"376","author":"Winstock","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1360-0443.2010.03130.x","article-title":"Mephedrone, new kid for the chop?","volume":"106","author":"Winstock","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2012.01.019_bib40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3109\/15563650.2010.531021","article-title":"Case series of individuals with analytically confirmed acute mephedrone toxicity","volume":"48","author":"Wood","year":"2010","journal-title":"Clin Toxicol"},{"issue":"Suppl 2","key":"10.1016\/j.neuroscience.2012.01.019_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1528-1157.2002.043s2028.x","article-title":"Psychostimulants and epilepsy","volume":"43","author":"Zagnoni","year":"2002","journal-title":"Epilepsia"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T21:26:05Z","timestamp":1543267565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452212000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":42,"alternative-id":["S0306452212000413"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2012.01.019","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}